Canon Medical partners with ACT Genomics!


Canon Medical System Corporation officially acquired ACT Genomics’ joint venture company in Japan, ACTmed! ACT Genomics will transfer its clinical NGS technology to ACTmed, making ACT Genomics the first Taiwanese biotech company to transfer technology to a major medical company in Japan. ACT Genomics will also help ACTmed operate cancer genomic profiling service in Japan and be the exclusive provider for analyzing the sequencing data generated by ACTmed.

Through this partnership, ACT Genomics and Canon Medical will utilize cancer genomic testing to provide cancer treatment selection and disease monitoring with better precision for patients in Japan.